Topic: Acne

News | March 25, 2019

Biofrontera Acquires Cutanea Life Sciences

Biofrontera Inc., USA entered into an agreement to acquire all shares in Cutanea Life Sciences, Inc., USA through its subsidiary Biofrontera Newderm LLC as the acquirer, with Maruho Co., Ltd., Japan as the seller. Maruho holds approximately...

Let's Play Buzzword Bingo

This is dedicated to our friends in pharma…and you know who you are.

Neal Bhatia, MD, FAAD

Every industry has its own vocabulary and script. In medicine, especially in dermatology training, the fundamentals start with vocabulary. Morphology, pathology, and physical exam findings all have unique descriptions and words that take...

Read Article

Features | March 2019

Dealing with Prescription Prior Authorization in Dermatology

Complaints and concerns abound, but remedies are slow in coming.

Bonnie Darves

Dermatologists and practice staff daily must surmount numerous administrative hurdles to help ensure that their patients receive recommended care and treatment and that the patient’s insurance plan covers what’s been prescribed....

Read Article

Hot Topic: Hormone Inhibitors for Acne

Video | March 25, 2019

Diane Berson, MD talks to Joel L. Cohen, MD about current and investigational hormone inhibitors for the treatment of acne. She discusses the safety and efficacy of spironolactone for adult female patients, especially those who suffer from cyclical acne. She also discusses a new topical androgen receptor inhibitor that is currently being investigated for treating acne by reducing sebum production.

Watch Video

The Latest in Acne

Video | March 25, 2019

Hot Topic: Hormone Inhibitors for Acne

Diane Berson, MD talks to Joel L. Cohen, MD about current and investigational hormone inhibitors for the treatment of acne. She discusses the safety...

News | March 25, 2019

Biofrontera Acquires Cutanea Life Sciences

Article | March 2019 Supplement

SCALE Notes

News and views from Music City SCALE

Article | News | March 2019

Recent Developments

Article | Editor's Message | March 2019

Let's Play Buzzword Bingo

This is dedicated to our friends in pharma…and you know who you are.

Neal Bhatia, MD, FAAD

Article | Features | March 2019

Dealing with Prescription Prior Authorization in Dermatology

Complaints and concerns abound, but remedies are slow in coming.

Bonnie Darves

News | March 11, 2019

Calling All Students: Ortho Dermatologics Now Accepting Applications for the 2019 Aspire Higher Scholarship Program

News | March 7, 2019

New Mouse Model Validates How “Good” and “Bad” Bacteria Affect Acne

News | March 5, 2019

Get to Know the Dermatology Hall of Fame's 2019 Inaugural Class of Inductees

News | March 1, 2019

Study: Isotretinoin Does Not Raise Depression Risk

Article | February 2019

Perspective: Mental Health is Skin Health

The evidence is in: Mental well-being influences the skin.

Helen Taylor, PhD

Article | February 2019

Long-term Management Strategies for AD, Melasma, and More

After the acute treatment phase, experts urge a long-view on management.

Article | February 2019

New in My Practice Rx: Seysara (sarecycline)

With Linda Stein Gold, MD

Article | February 2019

The Skin After Acne: Focus on Calming and Repair

Most patients will always remain acne-prone, but the right interventions can keep their skin healthy.

Nancy J. Samolitis, MD, FAAD

Article | News | February 2019

Recent Developments

News | February 14, 2019

Rodan & Fields Takes on Teen Acne with Spotless

News | February 1, 2019

Vyome Secures $22M to Advance Dermatology Pipeline

News | January 17, 2019

Almirall's Seysara Now Available

News | January 16, 2019

Dermatologists Prescribe the Most Antibiotics, But Usage Is Changing

Article | December 2018

Micromanagement: Microparticles Enhance Outcomes of Energy-based Acne Care

With recent FDA-clearance, microparticles are available to support Nd:YAG based treatment of inflammatory acne.

With Ashish Bhatia, MD and Ted Lain, MD

And

are now a part of the new and improved

Topics:

Topic: Acne

Biofrontera Acquires Cutanea Life Sciences

Editor's Message | March 2019

Let's Play Buzzword Bingo

This is dedicated to our friends in pharma…and you know who you are.

Neal Bhatia, MD, FAAD

Features | March 2019

Dealing with Prescription Prior Authorization in Dermatology

Complaints and concerns abound, but remedies are slow in coming.

Bonnie Darves

Hot Topic: Hormone Inhibitors for Acne

Video | March 25, 2019

The Latest in Acne

Video | March 25, 2019

Hot Topic: Hormone Inhibitors for Acne

News | March 25, 2019

Article | March 2019 Supplement

SCALE Notes

Article | News | March 2019

Recent Developments

Article | Editor's Message | March 2019

Let's Play Buzzword Bingo

Article | Features | March 2019

Dealing with Prescription Prior Authorization in Dermatology

News | March 11, 2019

News | March 7, 2019

News | March 5, 2019

News | March 1, 2019

Article | February 2019

Perspective: Mental Health is Skin Health

Article | February 2019

Long-term Management Strategies for AD, Melasma, and More

Article | February 2019

New in My Practice Rx: Seysara (sarecycline)

Article | February 2019

The Skin After Acne: Focus on Calming and Repair

Article | News | February 2019

Recent Developments

News | February 14, 2019

News | February 1, 2019

News | January 17, 2019

News | January 16, 2019

Article | December 2018

Micromanagement: Microparticles Enhance Outcomes of Energy-based Acne Care

Popular Videos

Hot Topic: Hormone Inhibitors for Acne

A Bad Acne Day: Dealing with a Capricious Disease

Top News Stories

March 25, 2019

March 11, 2019

Top Articles

Micromanagement: Microparticles Enhance Outcomes of Energy-based Acne Care

Therapeutics Update: Notable Approvals in 2017